Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition.

Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition.
复制标题

DOI:
10.1038/ncomms7139
复制
发表时间:
2015-02-11
影响因子:
16.6
通讯作者:
Sengupta S
Sengupta S
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Goldman A;Majumder B;Dhawan A;Ravi S;Goldman D;Kohandel M;Majumder PK;Sengupta S

文献摘要

参考文献

被引文献

相似文献

Understanding the emerging models of adaptive resistance is key to overcoming cancer chemotherapy failure. Using human breast cancer explants, in vitro cell lines, mouse in vivo studies and mathematical modelling, here we show that exposure to a taxane induces phenotypic cell state transition towards a favoured transient CD44HiCD24Hi chemotherapy-tolerant state. This state is associated with a clustering of CD44 and CD24 in membrane lipid rafts, leading to the activation of Src Family Kinase (SFK)/hemopoietic cell kinase (Hck) and suppression of apoptosis. The use of pharmacological inhibitors of SFK/Hck in combination with taxanes in a temporally constrained manner, where the kinase inhibitor is administered post taxane treatment, but not when co-administered, markedly sensitizes the chemotolerant cells to the chemotherapy. This approach of harnessing chemotherapy-induced phenotypic cell state transition for improving antitumour outcome could emerge as a translational strategy for the management of cancer. Adaptive resistance is an emerging cause of chemotherapy failure in cancer. Here the authors show that adaptive resistance to taxanes is mediated by the upregulation of SFK/Hck survival signalling, and that sequential administration of taxanes and SFK/Hck inhibition restores tumor cell chemosensitivity.
DOI: 10.1186/1471-2199-8-45
发表时间: 2007-05-30
影响因子: --
作者:
Paliwal P;Radha V;Swarup G
通讯作者: Swarup G
DOI: 10.1186/bcr1982
发表时间: 2008
影响因子: 7.4
作者:
Fillmore, Christine M.;Kuperwasser, Charlotte
通讯作者: Kuperwasser, Charlotte
DOI: 10.1371/journal.ppat.1002121
发表时间: 2011-07
期刊: PLoS pathogens
影响因子: 6.7
作者:
Dawson CC;Intapa C;Jabra-Rizk MA
通讯作者: Jabra-Rizk MA
DOI: 10.1002/cncr.26204
发表时间: 2012-01-01
期刊: Cancer
影响因子: 6.2
作者:
Araujo JC;Mathew P;Armstrong AJ;Braud EL;Posadas E;Lonberg M;Gallick GE;Trudel GC;Paliwal P;Agrawal S;Logothetis CJ
通讯作者: Logothetis CJ
DOI: 10.1242/dev.080531
发表时间: 2013-01-01
期刊: DEVELOPMENT
影响因子: 4.6
作者:
Fox, Donald T.;Duronio, Robert J.
通讯作者: Duronio, Robert J.